Latest Capital Raising And Funding News

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.

Kingston Resources has boosted the Southern Ore Zone (SOZ) Mineral Resource at Mineral Hill by 50%, expanding the mining inventory and underpinning plans for reserve growth and plant expansion.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

Western Australia's State Government has backed VRX Silica's land swap proposal at Muchea, unlocking access to a significantly larger high-grade silica sand resource with lower environmental impact and paving the way for downstream glass manufacturing.

Killi Resources has received regulatory approval to launch a major drilling campaign at its newly acquired Lodestone iron ore project, aiming to expand and upgrade a 110Mt inferred resource with a high-purity magnetite concentrate.

BOA Resources Ltd has voluntarily suspended trading of its shares on the ASX pending a potential acquisition announcement, with the suspension expected to last up to five trading days.

Acrow Limited (ASX:ACF) is set to expand its Industrial Access and Construction Services footprint with a $54.5 million acquisition of Ausgroup and Preston SuperDeck, funded by a fully underwritten $70 million equity raise and a $10 million share purchase plan. The company also upgraded its FY27 revenue and EBITDA guidance by 21% and 15% respectively.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

Trek Metals has kicked off its first Reverse Circulation drilling campaign at the Kuro manganese discovery near Christmas Creek, aiming to test the depth and extent of high-grade mineralisation identified at surface.

Megaport Limited is raising approximately A$827 million through a fully underwritten entitlement offer to finance four major AI contracts and build an on-demand GPU Pool, aiming to establish a globally-distributed AI inference cloud.

Vinyl Group has acquired Time Out Australia from Time Out England for nominal consideration, boosting its digital audience reach to 55% of Australians and completing a $2.4 million placement to fund integration. The acquisition is expected to be earnings accretive in FY27, reinforcing Vinyl's position as a leading cultural media platform.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.